|Values are valid only on day of printing.|
Monitoring treatment of patients with porphyria cutanea tarda
Plasma specimens from patients with active porphyria cutanea tarda, congenital erythropoietic porphyria, and erythropoietic protoporphyria may exhibit increased plasma porphyrin levels. However, a definitive diagnosis cannot be made by plasma analysis alone.
Plasma porphyrins are most appropriate for monitoring patients being treated for porphyria cutanea tarda.
Analysis of plasma porphyrins is suitable for individuals with bullous dermatosis who are in chronic renal failure and unable to provide a urine specimen.
|Test ID||Reporting Name||Available Separately||Always Performed|
|PFP||Porphyrins, Fractionation, P||No||No|
If total porphyrins are >1.0 mcg/dL, then PFP / Porphyrins, Fractionation, Plasma will be performed at an additional charge.
The following algorithms are available in Special Instructions:
-Porphyria (Acute) Testing Algorithm
-Porphyria (Cutaneous) Testing Algorithm
-The Heme Biosynthetic Pathway
PTP: Extraction and Scanning Spectrofluorometry
PFP: High-Performance Liquid Chromatography (HPLC)